Cristina Carniti

11PUBLICATIONS
24CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 10, 2026
Longitudinal Monitoring of Measurable Residual Disease in Chronic Lymphocytic Leukemia Patients Treated With Venetoclax: Results of a Prospective Multicenter Real-Life Study.

Lucia Farina, Alessandro Noto, Antonella Aiello

|Dec 23, 2024
Brexucabtagene autoleucel in-vivo expansion and BTKi refractoriness have a negative influence on progression-free survival in mantle cell lymphoma: Results from CART-SIE study.

Federico Stella, Annalisa Chiappella, Martina Magni

|Feb 15, 2024
Monocytes in leukapheresis products affect the outcome of CD19-targeted CAR T-cell therapy in patients with lymphoma.

Cristiana Carniti, Nicole M Caldarelli, Luca Agnelli

|Jan 04, 2024
Prognostic impact of pretreatment cell-free DNA concentration in newly diagnosed peripheral T-cell lymphomas.

E Fardella, G Zanirato, M Magni

|Nov 17, 2022
Combination of Deauville score and quantitative positron emission tomography parameters as a predictive tool of anti-CD19 chimeric antigen receptor T-cell efficacy.

Anna Guidetti, Anna Dodero, Alice Lorenzoni

|May 18, 2022
Phenotypic Composition of Commercial Anti-CD19 CAR T Cells Affects In Vivo Expansion and Disease Response in Patients with Large B-cell Lymphoma.

Chiara Monfrini, Federico Stella, Vanessa Aragona

Pageof 2

Frequent Collaborators

6 joint publications

Paolo Corradini

3 joint publications

Annalisa Chiappella

3 joint publications

Martina Magni

2 joint publications

Eugenio Fardella